Squarepoint’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.4M | Buy |
+418,660
| New | +$9.8M | 0.01% | 1085 |
|
|
2025
Q4 | – | Sell |
-33,622
| Closed | -$389K | – | 4256 |
|
|
2025
Q3 | $389K | Sell |
33,622
-59,950
| -64% | -$702K | ﹤0.01% | 3460 |
|
|
2025
Q2 | $1.15M | Buy |
+93,572
| New | +$1.18M | ﹤0.01% | 2544 |
|
|
2024
Q1 | – | Sell |
-9,114
| Closed | -$204K | – | 4004 |
|
|
2023
Q4 | $204K | Sell |
9,114
-18,689
| -67% | -$386K | ﹤0.01% | 3583 |
|
|
2023
Q3 | $562K | Buy |
27,803
+19,849
| +250% | +$450K | ﹤0.01% | 2708 |
|
|
2023
Q2 | $203K | Buy |
7,954
+1,008
| +15% | +$26.5K | ﹤0.01% | 3217 |
|
|
2023
Q1 | $207K | Buy |
+6,946
| New | +$202K | ﹤0.01% | 2787 |
|
|
2022
Q4 | – | Sell |
-23,805
| Closed | -$518K | – | 3174 |
|
|
2022
Q3 | $518K | Buy |
+23,805
| New | +$622K | ﹤0.01% | 2189 |
|
|
2021
Q3 | – | Sell |
-25,876
| Closed | -$941K | – | 2895 |
|
|
2021
Q2 | $941K | Buy |
25,876
+10,571
| +69% | +$437K | ﹤0.01% | 1673 |
|
|
2021
Q1 | $669K | Buy |
+15,305
| New | +$718K | ﹤0.01% | 1810 |
|
|
2020
Q4 | – | Sell |
-20,858
| Closed | -$693K | – | 2907 |
|
|
2020
Q3 | $693K | Buy |
20,858
+2,734
| +15% | +$87.4K | 0.01% | 1207 |
|
|
2020
Q2 | $533K | Buy |
+18,124
| New | +$525K | 0.01% | 1290 |
|
|
2020
Q1 | – | Sell |
-6,876
| Closed | -$232K | – | 1858 |
|
|
2019
Q4 | $232K | Buy |
+6,876
| New | +$249K | ﹤0.01% | 2162 |
|
|
2019
Q3 | – | Sell |
-7,821
| Closed | -$341K | – | 2336 |
|
|
2019
Q2 | $341K | Buy |
+7,821
| New | +$335K | ﹤0.01% | 1872 |
|
|
2019
Q1 | – | Sell |
-47,037
| Closed | -$2.11M | – | 2131 |
|
|
2018
Q4 | $2.11M | Buy |
47,037
+28,850
| +159% | +$1.51M | 0.02% | 661 |
|
|
2018
Q3 | $1.25M | Sell |
18,187
-10,893
| -37% | -$701K | 0.01% | 892 |
|
|
2018
Q2 | $1.67M | Buy |
29,080
+14,418
| +98% | +$762K | 0.02% | 696 |
|
|
2018
Q1 | $676K | Sell |
14,662
-11,734
| -44% | -$557K | 0.01% | 971 |
|
|
2017
Q4 | $1.22M | Sell |
26,396
-10,475
| -28% | -$481K | 0.02% | 745 |
|
|
2017
Q3 | $1.66M | Buy |
36,871
+21,338
| +137% | +$911K | 0.03% | 560 |
|
|
2017
Q2 | $610K | Sell |
15,533
-9,806
| -39% | -$371K | 0.01% | 886 |
|
|
2017
Q1 | $965K | Buy |
25,339
+16,545
| +188% | +$645K | 0.03% | 622 |
|
|
2016
Q4 | $325K | Buy |
+8,794
| New | +$314K | 0.01% | 1106 |
|
|
2015
Q1 | – | Sell |
-6,200
| Closed | -$282K | – | 420 |
|
|
2014
Q4 | $282K | Buy |
+6,200
| New | +$244K | 0.27% | 139 |
|
Other funds holding AVNS
NAM
TAL
FTCM
Squarepoint's AVNS Position: Q2 2026 in Review
Squarepoint opened a new position in Avanos Medical (AVNS) in Q2 2026: 418,660 shares worth $10.4M. The stake represents 0.01% of the portfolio and ranks #1085 among its holdings. This is a return to the name: Squarepoint previously reported a position in AVNS as recently as Q3 2025.
Squarepoint first reported a position in AVNS in Q4 2014 and has held it in 24 quarters since. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.
- Squarepoint held 418,660 shares of Avanos Medical worth $10.4M as of Q2 2026.
- Avanos Medical was a new Squarepoint position in Q2 2026.
- Avanos Medical made up 0.01% of Squarepoint's portfolio in Q2 2026, its #1085 holding.
- Squarepoint first reported a position in Avanos Medical in Q4 2014 and has held it in 24 quarters since.
- 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.
Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.